The realm of clinical trials and medical research is one that is constantly growing and expanding. The onset of the Covid-19 pandemic drew a lot more attention to this industry as clinical trials played a crucial role in finding a solution for a global pandemic. Clinical research organizations (CROs) are independent organizations that provide outsourced clinical trial services to medical device and pharmaceutical companies to enhance efficiency and reduce costs in the complex development phase of new treatments.
Recipient of the Frost & Sullivan 2021 Asia-Pacific Competitive Strategy Leadership Award, George Clinical is a leading global CRO founded in Asia-Pacific and driven by scientific expertise and operational excellence. A subsidiary of The George Institute for Global Health, it is a leading example of clinical trial scientific leadership. George Clinical has a global presence with a strong focus on the Asia Pacific region, Europe and the US, with offices established in 38 countries.
Offering a wide array of services, George Clinical identifies itself as a full-service CRO with therapeutic strengths in kidney and metabolic, oncology, cardiovascular and respiratory. Among the numerous services they provide are program and protocol design, scientific leadership, project management, clinical monitoring, regulatory services, medical monitoring, safety services including pharmacovigilance and endpoint adjudication, data management, statistics and health economics.
George Clinical's Scientific Leadership team sets
them apart from other CROs. These globally recognized and influential researchers/clinicians give George Clinical's clients scientific and operational excellence that enhances every aspect of studies – from trial design and strategy to site identification and increased recruitment and retention success. Their in-country knowledge, experience and established relationships help create more effective and efficient trial solutions for clients and patients alike.
Science. Service. Solutions.
George Clinical is the only mid-sized CRO with a strong presence in Europe and the US. Their mid-size status plays to their favour by allowing them greater flexibility in designing customized individual services and solutions for all clients. Their detailed in-country knowledge, experience and established relationships allow their national and scientific leaders to be engaged with project teams in all studies to meet overall client strategic goals and address day-to-day issues. Their strong recruitment and retention track record often exceed expectations even in the toughest of markets like Taiwan, Korea, India and China.
An example of George Clinical's commitment to provide better solutions for clients is the creation of the Global Kidney Patient’s Trial Network (GKPTN). This network tracks thousands of kidney patients in a multicountry registry and gathers vital patient data and critical factors on treatment. The aim of the network is to strengthen the global kidney disease research community's capacity to provide rapid translation of new interventions from research into practice. Withthe GKPTN, George Clinical’s scientists will be able to formulate the collected data into successful tracks for future studies, and their clients can get unique insights far beyond feasibility.
Offering a wide array of services, George Clinical identifies itself as a full-service CRO with therapeutic strengths in kidney and metabolic, oncology, cardiovascular and respiratory
In fulfilling their commitment to global research aimed at improving the lives of patients' worldwide, George Clinical is positioned for continued growth across APAC, Europe and the US with reatest growth in China, India and Southeast Asia. With a stable and growing team in all locations, they are poised for continued success by focusing their attention on Science, Service and Solutions in their core therapeutic areas. Their commitment to providing leadership, efficiency, cost-effectiveness, and results for their client partners and their respect for patient’s safety and care are embedded in George Clinical's core values and practiced at all levels of the organization.
With their growth revenue averaging more than 20 percent per year and their sales growing over 20 percent per year, George Clinical is currently focused on expanding their presence in the APAC region and attracting clients with multi-national trial and large patient populations.
We use cookies to ensure you get the best experience on our website. Read more...
